AFP and hepatocellular carcinoma: In the absence of a standard treatment, clinicians often determine the dominant phenotype of tumor on the basis of radiologic characteristics and the presence of tumor markers, such as AFP or carbohydrate antigen 19-9 (CA 19-9), and recommend standard of care treatment for either HCC or CC.